Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis

Autologous antigen-specific therapies based on tolerogenic dendritic cells (tolDC) offer the possibility to treat autoimmune diseases by restoring homeostasis and targeting specifically autoreactive responses. Here, we explore the hypothesis that systemic inflammation occurring in autoimmune disease...

Full description

Bibliographic Details
Main Authors: Bibiana Quirant-Sánchez, María José Mansilla, Juan Navarro-Barriuso, Silvia Presas-Rodríguez, Aina Teniente-Serra, Federico Fondelli, Cristina Ramo-Tello, Eva Martínez-Cáceres
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Biomedicines
Subjects:
combined therapy
antigen-specific therapies
immunomodulatory
multiple sclerosis
Online Access:https://www.mdpi.com/2227-9059/9/12/1758

Internet

https://www.mdpi.com/2227-9059/9/12/1758

Similar Items